Rua Bioscience expands product range in New Zealand

PO Box 1387, Gisborne 4040, Aotearoa New Zealand | 0800 RUABIO | www.ruabio.com




FOR PUBLIC RELEASE

NZX Limited
Wellington

29 November 2024

Rua Bioscience expands product range in New Zealand

Rua Bioscience is pleased to annouce the release of our newest dried flower product,
marking another significant milestone for the company. This is the second flower product
launched by Rua in New Zealand in the last six months, reflecting our ongoing efforts to grow
our portfolio in our home market of Aotearoa New Zealand.

This new product has already generated significant demand ahead of its release, and Rua
expects market uptake to be strong.

The New Zealand market, along with our other key markets, is still showing evidence of
substantial growth. The market more than doubled in size between FY23 and FY24 which
suggests greater acceptance by Doctors, Pharmacists and Patients.


Packs for Medicinal Cannabis products prescribed in NZ
Source: NZ Ministry of Health, Medicinal Cannabis Agency

As part of our dedication to supporting equitable access to medicines, this product will also
be included in Compassionate Access Programme. This initiative reflects our commitment to
redcuing barriers to access for those paitents least able to afford this medicine.

3,600
14,000
32,000
43,000
106,000
263,000
FY19 FY20 FY21 FY22 FY23 FY24
MARKET UPDATE

PO Box 1387, Gisborne 4040, Aotearoa New Zealand | 0800 RUABIO | www.ruabio.com
Paul Naske, CEO of Rua Bioscience says “Whilst we are focused on large export markets, this
launch is testament to our connection to Aotearoa New Zealand. We’re immensly proud to
bring another product to our home market”.

This significant achievement reflects Rua’s continued focus on sales and revenue growth and
our commitment to delivering for the people and communities of Aotearoa New Zealand.

ENDS  
 
The person who authorised this announcement:

Paul Naske
Chief Executive Officer
paul.naske@ruabio.com
+64 21 445154